The transformational research taking place in the Cumming School of Medicine’s Hotchkiss Brain Institute (HBI) has already earned the University of Calgary a reputation for neurological and mental health research excellence. With today’s announcement that the HBI will lead the University of Calgary’s Brain and Mental Health research strategy, the university’s ability to lead on the research frontier of the healthy human brain will be made even stronger.
A drug first used to treat patients with heart attacks is safe for people afflicted by minor strokes caused by a blockage in the brain, potentially helping them avoid disability and death, says a Canada-wide study led by Dr. Shelagh Coutts, a member of the University of Calgary’s Hotchkiss Brain Institute (HBI).
Canadian researchers have completed an international randomized controlled trial showing that a clot retrieval procedure, known as endovascular treatment (ET), can dramatically improve patient outcomes after an acute ischemic stroke. The study, led by researchers at the University of Calgary’s Hotchkiss Brain Institute (HBI), shows a dramatic improvement in outcomes and a reduction in deaths from stroke. The results of this study were published in the Feb. 11 online edition of the New England Journal of Medicine (NEJM).